Patents
Patents for C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
07/2003
07/08/2003US6590107 Intermediate 1,3-oxaselenolane lactone
06/2003
06/19/2003US20030114437 Protease inhibitors
05/2003
05/15/2003WO2003040160A1 Rhodium and iridium complexes
05/02/2003EP1306376A1 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist
05/01/2003WO2003035646A2 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist
04/2003
04/01/2003US6541618 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds
03/2003
03/19/2003CN1404476A Glycosidase inhibitors and preparation thereof
02/2003
02/06/2003WO2003010154A1 Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses
02/06/2003US20030028015 Especially bi- or tri- selophenes
01/2003
01/29/2003EP1278502A2 Protease inhibitors
01/28/2003US6511681 Solubility and bioavailability of azole antifungal medicaments
12/2002
12/31/2002US6500845 Activating cytokine release using immunosuppressants such as 2-(3-methyl-2-oxo-piperidin-3-yl)-benzo(d)isoselenazol-3-one, racemic mixtures or isomers having dimensional stability, prepared in the presence of reducing agent
12/25/2002CN1387528A Heterocyclic substd, pyrazolones
12/24/2002US6497905 Aqueous solubility pharmaceutical formulations
11/2002
11/19/2002US6482950 Squarylium compounds, and processes and intermediates for the synthesis of these compounds
11/19/2002US6482918 High refractive index, low dispersion and excellent optical property, and is used for a glasses lens, camera lens, prism, substrate for an information recording medium, pick up lens, optical fiber, optical filter
11/13/2002CN1379768A Improved aqueous solubility pharmaceutical formulations
10/2002
10/16/2002EP1248779A2 Glycosidase ihhibitors and preparation thereof
09/2002
09/24/2002US6455573 Synthesizing salacinol, its stereoisomers, and non-naturally occurring selenium and nitrogen analogues thereof
09/24/2002US6455525 Heterocyclic substituted pyrazolones
08/2002
08/29/2002US20020120097 High refractive index, low dispersion and excellent optical property, and is used for a glasses lens, camera lens, prism, substrate for an information recording medium, pick up lens, optical fiber, optical filter
07/2002
07/31/2002EP1226141A1 Heterocyclic substituted pyrazolones
05/2002
05/30/2002WO2002042281A1 Substituted 5-aryl and 5-heteroaryl-2-(2-hydroxyphenyl)-2h-benzotriazole derivatives as uv absorbers
04/2002
04/30/2002US6379707 Solid solution of amorphous pharmaceutically active agent, pharmaceutically acceptable hydrophobic vehicle, stabilizer, disintegrant; shelf life
04/10/2002EP1021178A4 Selenophene anti-tumor agents
04/04/2002WO2001089451A3 Protease inhibitors
04/02/2002US6365335 Sensitivity and decreased in residual color
03/2002
03/28/2002US20020037324 Aqueous solubility pharmaceutical formulations
02/2002
02/19/2002US6348596 Non-fluorescent asymmetric cyanine dye compounds useful for quenching reporter dyes
01/2002
01/31/2002US20020012706 Method of making granular pharmaceutical vehicle
01/23/2002EP1049744B1 Asymmetric cyanine dye quenchers
12/2001
12/19/2001EP1163234A1 Improved aqueous solubility pharmaceutical formulations
11/2001
11/29/2001WO2001089451A2 Protease inhibitors
11/29/2001WO2001049674A3 Glycosidase inhibitors and preparation thereof
11/29/2001CA2406829A1 Protease inhibitors
11/21/2001EP0917555B1 Electrochrome system
10/2001
10/16/2001US6303747 Selenium-containing polythiol having 3 or more functional groups; monomers for preparing transparent optical material which has high refractive index, low dispersion and excellent optical properties
07/2001
07/12/2001WO2001049674A2 Glycosidase inhibitors and preparation thereof
07/12/2001CA2396688A1 Glycosidase inhibitors and methods of synthesizing same
06/2001
06/27/2001EP0701554B1 Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof
05/2001
05/10/2001WO2001032653A1 Heterocyclic substituted pyrazolones
05/10/2001CA2389807A1 Heterocyclic substituted pyrazolones
04/2001
04/24/2001US6221574 Spectral sensitizers
03/2001
03/06/2001US6197777 Synthesis, anti-human immunodeficiency virus, and anti-hepatitis B virus activities of 1,3-oxaselenolane nucleosides
02/2001
02/06/2001US6183878 Electrochromic system
11/2000
11/08/2000EP1049744A1 Asymmetric cyanine dye quenchers
09/2000
09/28/2000WO2000056726A1 Improved aqueous solubility pharmaceutical formulations
09/26/2000US6124424 A transparent optical lens is obtained by cast-polymerizing at least one reactive monomer or oligomer having at least one selenium atom in its molecule; improved refractive index
07/2000
07/26/2000EP1021178A1 Selenophene anti-tumor agents
07/25/2000US6093532 Method for storing a biological organ transplant graft using a benzisoselen-azoline or -azine compound
06/2000
06/27/2000US6080868 As a quencher in a reporter-quencher energy-transfer dye pair for nucleic acid hybridization assays
06/06/2000US6071922 Synthesis, anti-human immunodeficiency virus, and anti-hepatitis B virus activities of 1,3-oxaselenolane nucleosides
05/2000
05/31/2000CN1255132A Synthesis, anti-human immunodeficiency virus and anti-hepatitis B virus activities of 1-3-oxaselenolane nucleosides
04/2000
04/19/2000CN1051546C Novel 1,1-bis(heteroazolyl) alkane derivatives and their use as neuroprotective agents
04/06/2000DE19845642A1 New indolyl-benzoxazole methin cyanine dyes are used for spectral sensitization of color photographic silver halide material, especially tabular grain material
01/2000
01/12/2000EP0970078A1 Synthesis, anti-human immunodeficiency virus and anti-hepatitis b virus activities of 1,3-oxaselenolane nucleosides
11/1999
11/03/1999EP0650599B1 Method of colorimetric analysis of malonic dialdehyde and 4-hydroxy-2-enaldehydes as indexes of lipid peroxidation, kits for carrying out said method, substituted indoles for use in said method and their preparation
10/1999
10/19/1999US5968920 Increase glutathione peroxidase activity for reducing levels of peroxides in cells or tissues
10/13/1999CN1045595C Process for the preparation of the intermediates used in the synthesis of 3-aminopiperidine derivatives
07/1999
07/29/1999WO1999037717A1 Asymmetric cyanine dye quenchers
07/06/1999US5919950 Squarylium compounds, and processes and intermediates for the synthesis of these compounds
05/1999
05/26/1999EP0917555A1 Electrochrome system
03/1999
03/09/1999US5880287 Polyoxyhydrocarbyl related products and methods for fluorescence assays
02/1999
02/17/1999EP0896972A1 Selenized transparent optical material
02/16/1999CA1340396C Functionalized conductive polymers and their use in diagnostic devices
12/1998
12/01/1998US5843971 1, 1-BIS (heteroazolyl) alkane derivatives and their use as neuroprotective agents
11/1998
11/11/1998CN1198816A Polyoxyhydrocarbyl related products and methods for fluorescence assays
09/1998
09/24/1998WO1998041522A1 Synthesis, anti-human immunodeficiency virus and anti-hepatitis b virus activities of 1,3-oxaselenolane nucleosides
08/1998
08/27/1998WO1998037117A1 Selenized transparent optical material
03/1998
03/24/1998US5731335 Nervous system disorders; stroke; antiischemic agents; cognition activators
03/10/1998US5726063 Diagnosis of disease, monitoring treatment
02/1998
02/24/1998CA2075750C Composition and method for treating cancer
02/12/1998WO1998005737A1 Electrochrome system
02/12/1998DE19631729A1 Elektrochromes System Electrochromic system
12/1997
12/11/1997WO1997046225A1 Selenophene anti-tumor agents
11/1997
11/05/1997EP0804447A1 Procedures for obtaining ribo-c-nucleosides
09/1997
09/24/1997CN1035944C Method for preparing 3-aminopiperidine derivs. and related nitrogen-contg. heterocycles
09/23/1997US5670530 Anti-cancer composition comprising rhodacyanine compound and cyclodextrin
09/09/1997US5665747 Treating nervous system, psychological, and brain disorders
08/1997
08/19/1997CA1339313C Pyrimidine derivatives
05/1997
05/21/1997CN1150426A Novel 1,1-bis (heteroazolyl) alkane derivatives and their use as neuroprotective agents
04/1997
04/22/1997CA2029776C Selenophen derivatives, a preparation process of the same and therapeutical compositions containing them
04/08/1997US5618950 Electrophotographic elements and soluble cyclic sulfone electron transport agents
04/02/1997EP0765325A1 Novel 1,1-bis(heteroazolyl)alkane derivatives and their use as neuroprotective agents
03/1997
03/04/1997US5607956 1-heteroazolyl-1-heterocyclyl alkane derivatives and their use and their use as neuroprotective agents
02/1997
02/06/1997WO1996041144A3 Polyoxyhydrocarbyl marker products and methods for fluorescence assays
01/1997
01/07/1997CA2033497C 3-aminopiperidine derivatives and related nitrogen containing heterocycles
12/1996
12/19/1996WO1996041144A2 Polyoxyhydrocarbyl marker products and methods for fluorescence assays
11/1996
11/19/1996US5576429 5-substituted pyrimidine nucleosides and nucleotides
07/1996
07/17/1996CN1126994A Novel (1-heteroazolyl-1-heterocyclyl) alkane derivatives and their use as neuroprotective agents
04/1996
04/30/1996US5512428 Photographic recording materials
04/24/1996EP0707584A1 Novel (1-heteroazolyl-1-heterocyclyl)alkane derivatives and their use as neuroprotective agents
03/1996
03/20/1996EP0701554A1 Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof
03/19/1996US5500317 Dicyano-sulfone compound
01/1996
01/10/1996EP0691579A1 Electrophotographic elements and soluble cyclic sulfone electron transport agents
01/10/1996EP0691333A2 Pyrimidine derivatives, process for their preparation and their use as precursors
12/1995
12/27/1995EP0688771A1 Use of lactam compounds as pharmaceutical agents
12/25/1995CA2152432A1 Use of a lactam compound as pharmaceutically active ingredient
12/14/1995WO1995033747A1 Novel 1,1-bis(heteroazolyl)alkane derivatives and their use as neuroprotective agents
12/14/1995CA2190128A1 Novel 1,1-bis(heteroazolyl)alkane derivatives and their use as neuroprotective agents
1 2 3 4 5